中性粒细胞胞外诱捕网在脑梗死发病机制中的研究进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
黄璐璐,黄建敏
文章摘要
脑梗死,又称缺血性脑卒中,其病理基础在于脑血栓形成、动脉粥样硬化等因素造成的脑部供血不足或中断,继而引发脑组织缺血缺氧,最终导致脑组织坏死。脑梗死在临床中较为常见,近年发病率显著上升,带来严重的危害[1,2]。该病发病急、进展快、致残率高、致死率高[3,4],是世界范围内的主要死亡及残疾疾病之一。近年来,在我国发病率逐年上升,已经成为全世界脑卒中发病率最高的国家之一,给患者家庭和社会带来了沉重的负担。脑梗死发病机制非常复杂,涉及多种信号通路和多种病理过程,其中炎症信号通路是脑梗死发生发展过程中的关键因素之一。中性粒细胞胞外诱捕网(NETs)是中性粒细胞释放的一种由DNA、组蛋白和颗粒蛋白组成的网状复合物[5],促使脑血栓的形成,在脑梗死的发生发展过程中发挥重要作用,但发病机制尚未阐明。研究表明,NETs在炎症反应、血栓形成、溶栓抵抗、血管生成、动脉粥样硬化、血脑屏障损伤等病理过程中扮演了关键角色。推测NETs可能与脑梗死的发病机制密切存在相关,因此,深入研究NETs参与脑梗塞发病的具体机制对探讨新治疗方法改善预后将具有重要的现实意义。本文对NETs与炎症反应、免疫细胞、血栓形成与溶栓抵抗、血脑屏障、血管生成、动脉粥样硬化关系的研究进展进行综述。
文章关键词
NETs;脑梗死;发病机制
参考文献
[1] 郝若飞,范雪松.sdLDL-C水平及其与LDL-c比值对急性脑梗死患溶栓后出血转化的预测价值[J].国际检验医学杂志,2023, 44(2):183-186,191. [2] 卢小燕,余锋,赵兴利.静脉溶栓桥接机械取栓对急性脑梗死的临床疗效及预后因素分析[J].脑与神经疾病杂志,2023,31(2):110-113. [3] 蒋孝宗,张守成,马兰.可溶性凝集素样氧化型低密度脂蛋白受体-1在急性缺血性脑卒中表达及与静脉溶栓预后和静脉溶栓后脑出血转化的关系[J].安徽医药,2023,27(2):370-374. [4] 李冬梅,陈超,李弘,等.静脉溶栓24 h内使用替罗非班对不稳定穿支动脉梗死的有效性和安全性[J].中国老年学杂志,2023, 43(3):520-523. [5] Pinegin B,Vorobjeva N,Pinegin V.Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity[J].Autoimmunity Reviews,2015,14(7):633-640. [6] Vidale S,Consoli A,Arnaboldi M,et al.Postischemic inflammation in acute stroke[J].Journal of Clinical Neurology,2017,13(1):1. [7] Löuvbld K,Baird A E,Schlaug G,et al.Ischemic lesion volumes in acute stroke by diffusion‐weighted magnetic resonance imaging correlate with clinical outcome[J].Annals of Neurology,1997,42(2):164-170. [8] 胡月华.抗炎和促炎因子失衡在颅内动脉粥样硬化性脑梗死患者中的作用研究[D].第三军医大学,2011. [9] Kawabori M,Yenari M.Inflammatory responses in brain ischemia[J].Current Medicinal Chemistry,2015,22(10):1258-1277. [10] Kahlenberg J M,Carmona-Rivera C,Smith C K,et al.Neutrophil extracellular trap–associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages[J].The Journal of Immunology,2013,190(3):1217-1226. [11] Mussbacher M,Salzmann M,Brostjan C,et al.Cell type-specific roles of NF-κB linking inflammation and thrombosis[J].Frontiers in Immunology,2019,10:85. [12] Zhou W,Liesz A,Bauer H,et al.Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models[J].Brain Pathology,2013,23(1):34-44. [13] Wang Q,Tang X N,Yenari M A.The inflammatory response in stroke[J].Journal of Neuroimmunology,2007,184(1-2):53-68. [14] Knight J S,Luo W,O’Dell A A,et al.Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis[J].Circulation Research,2014,114(6):947-956. [15] Warnatsch A,Ioannou M,Wang Q,et al.Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis[J].Science,2015,349(6245):316-320. [16] Fuchs T A,Brill A,Duerschmied D,et al.Extracellular DNA traps promote thrombosis[J].Proceedings of the National Academy of Sciences,2010,107(36):15880-15885. [17] Campos J,Ponomaryov T,De Prendergast A,et al.Neutrophil extracellular traps and inflammasomes cooperatively promote venous thrombosis in mice[J].Blood Advances,2021,5(9):2319-2324. [18] Zhou Y,Tao W,Shen F,et al.The emerging role of neutrophil extracellular traps in arterial,venous and cancer-associated thrombosis[J]. Frontiers in Cardiovascular Medicine,2021,8:786387. [19] Yang J,Wu Z,Long Q,et al.Insights into immunothrombosis:The interplay among neutrophil extracellular trap,von willebrand factor,and ADAMTS13[J].Frontiers in Immunology,2020,11:610696. [20] Zhou P,Li T,Jin J,et al.Interactions between neutrophil extracellular traps and activated platelets enhance procoagulant activity in acute stroke patients with ICA occlusion[J].EBioMedicine,2020,53:102671. [21] Döring Y,Soehnlein O,Weber C.Neutrophil extracellular traps in atherosclerosis and atherothrombosis[J].Circulation Research,2017, 120(4):736-743. [22] Patel R B,Dhanesha N,Sutariya B,et al.Targeting neutrophilα9 improves functional outcomes after stroke in mice with obesity-induced hyperglycemia[J].Stroke,2023,54(9):2409-2419. [23] Ducroux C,Di Meglio L,Loyau S,et al.Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke[J].Stroke,2018,49(3):754-757. [24] Novotny J,Oberdieck P,Titova A,et al.Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction[J].Neurology,2020,94(22). [25] Longstaff C,VarjúI,Sótonyi P,et al.Mechanical stability and fibrinolytic resistance of clots containing fibrin,DNA,and histones[J].Journal of Biological Chemistry,2013,288(10):6946-6956. [26] Di Meglio L,Desilles J P,Mazighi M,et al.Thrombolysis-resistant intracranial clot[J].Neurology,2018,90(23):1075-1075. [27] Laridan E,Denorme F,Desender L,et al.Neutrophil extracellular traps in ischemic stroke thrombi[J].Annals of Neurology,2017, 82(2):223-232. [28] Fuchs T A,Brill A,Wagner D D.Neutrophil extracellular trap(NET)impact on deep vein thrombosis[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2012,32(8):1777-1783. [29] Yokel R A.Nanoparticle brain delivery:A guide to verification methods[J].Nanomedicine,2020,15(4):409-432. [30] Abbott N J,Rönnbäck L,Hansson E.Astrocyte–endothelial interactions at the blood–brain barrier[J].Nature Reviews Neuroscience, 2006,7(1):41-53. [31] Armulik A,GenovéG,Mäe M,et al.Pericytes regulate the blood–brain barrier[J].Nature,2010,468(7323):557-561. [32] Laridan E,Denorme F,Desender L,et al.Neutrophil extracellular traps in ischemic stroke thrombi[J].Annals of Neurology,2017, 82(2):223-232. [33] Cedervall J,Zhang Y,Huang H,et al.Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals[J].Cancer Research,2015,75(13):2653-2662. [34] 顾伟.Pad4抑制剂促进脑缺血再灌注后神经修复机制的研究[D].开封:河南大学,2023. [35] Huang W,Jiao J,Liu J,et al.MFG-E8 accelerates wound healing in diabetes by regulating“NLRP3 inflammasome-neutrophil extracellular traps”axis[J].Cell Death Discovery,2020,6(1):84. [36] Masucci M T,Minopoli M,Del Vecchio S,et al.The emerging role of neutrophil extracellular traps(NETs)in tumor progression and metastasis[J].Frontiers in Immunology,2020,11:1749. [37] 庞伯通,南淞华,陈芳芳,等.益气通脉方联合阿托伐他汀治疗缺血性中风恢复期气虚血瘀型合并颈动脉粥样硬化斑块[J].医药导报,2023,42(10):1511-1516. [38] 陈亚伦,宋彦,刚培,等.炎性指标对进展性脑梗死病灶损害程度影响以及对疾病进展方向预测效能的评价[J].中华老年心脑血管病杂志,2023,25(2):163-166. [39] Kong P,Cui Z Y,Huang X F,et al.Inflammation and atherosclerosis:Signaling pathways and therapeutic intervention[J].Signal Transduction and Targeted Therapy,2022,7(1):131. [40] 杜高辉,张青,魏宇淼.中性粒细胞胞外诱捕网在动脉粥样硬化中的研究进展[J].华中科技大学学报(医学版),2023,52(2):252-256. [41] 胡彦武,杨温欣,包小雪,等.葛根素改善动脉粥样硬化大鼠血脂异常及炎症反应的作用机制[J].医药导报,2021,40(2):175-179. [42] 许琳,杜肖彦.急性脑梗死患者炎症因子、血脂和氧化应激水平变化临床意义[J].内蒙古医科大学学报,2023,45(S1):1-3. [43] Xiao J,Padrick M M,Jiang T,et al.Acute ischemic stroke versus transient ischemic attack:Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions[J].Atherosclerosis,2021,319:72-78.
Full Text:
DOI